Black Friday saleUp to 70% OFF
CHENGDU OLYMVAX BIOPHARMACEUTICALSCHENGDU OLYMVAX BIOPHARMACEUTICALSCHENGDU OLYMVAX BIOPHARMACEUTICALS

CHENGDU OLYMVAX BIOPHARMACEUTICALS

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Forecast Seasonals

688319 fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

Chengdu Olymvax Biopharmaceuticals, Inc. engages in the research and development, manufacture, and sale of human-use vaccines. The company was founded on December 11, 2009 and is headquartered in Chengdu, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

688319 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company